OraSure Technologies, Inc. (OSUR) Q3 2025 Earnings Call Transcript

OraSure Technologies, Inc. ( OSUR ) Q3 2025 Earnings Call November 5, 2025 5:00 PM EST Company Participants Jason Plagman - Vice President of Investor Relations Carrie Eglinton Manner - President, CEO & Director Kenneth McGrath - Chief Financial Officer Conference Call Participants Steven Etoch - Stephens Inc., Research Division Presentation Operator Ladies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to the OraSure Technologies, Inc. 2025 Third Quarter Earnings Conference Call.

Seeking Alpha • Nov 6, 2025

OraSure Technologies (OSUR) Reports Q3 Loss, Lags Revenue Estimates

OraSure Technologies (OSUR) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to a loss of $0.01 per share a year ago.

Zacks Investment Research • Nov 6, 2025

OraSure to Announce Third Quarter 2025 Financial Results and Host Earnings Call on November 5th

BETHLEHEM, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering third quarter 2025 financial results and certain business developments for 5 p.m. ET on November 5, 2025.

GlobeNewsWire • Oct 29, 2025

OraSure Technologies Appoints Steven K. Boyd to its Board of Directors

Seasoned Investor with Deep Experience in the Healthcare and Medical Device Industries Brings Valuable Capital Markets Expertise and Investor Perspective  OraSure Board Has Added Three New Independent Directors in the Past Three Years Mara Aspinall to Step Down from the Board; Jack Kenny Appointed as Chair of the Board BETHLEHEM, Pa., Oct. 28, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OTI”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced the appointment of Steven K.

GlobeNewsWire • Oct 28, 2025

Exclusive: Altai Capital lays groundwork for board fight at OraSure Technologies, sources say

Altai Capital Management is preparing to launch a board fight at OraSure Technologies after the hedge fund, already one of the biggest owners of the medical device maker, increased its holdings, two people familiar with the matter told Reuters.

Reuters • Sep 9, 2025

Exclusive: Healthcare entrepreneur's letter threatens 'adversarial path' after OraSure Tech rebuffs bid

Prominent healthcare entrepreneur Ron Zwanziger warned on Monday he may pursue a more "adversarial path" if the OraSure Technologies board continues to resist his offer to buy the medical devices company, according to a letter seen by Reuters.

Reuters • Aug 25, 2025

OraSure (OSUR) Q2 Revenue Falls 43%

OraSure (OSUR) Q2 Revenue Falls 43%

The Motley Fool • Aug 6, 2025

OraSure Technologies, Inc. (OSUR) Q2 2025 Earnings Call Transcript

OraSure Technologies, Inc. (NASDAQ:OSUR ) Q2 2025 Earnings Conference Call August 5, 2025 5:00 PM ET Company Participants Carrie Eglinton Manner - President, CEO & Director Jason Michael Plagman - Vice President of Investor Relations Kenneth J. McGrath - Chief Financial Officer Conference Call Participants Noah Lewis - Raymond James & Associates, Inc., Research Division Operator Good day, and thank you for standing by.

Seeking Alpha • Aug 6, 2025

OraSure Technologies (OSUR) Reports Q2 Loss, Beats Revenue Estimates

OraSure Technologies (OSUR) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to earnings of $0.07 per share a year ago.

Zacks Investment Research • Aug 5, 2025

OraSure Appoints Anne Messing as Chief Commercial Officer

BETHLEHEM, Pa., Aug. 04, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OTI”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced that Anne Messing has joined OTI as Chief Commercial Officer.

GlobeNewsWire • Aug 4, 2025